Effects of Neprilysin Inhibition With ARNI (LCZ 696) on the Cardiorenal and Humoral Response to Acute Saline Volume Expansion in DM With and Without PDD
Latest Information Update: 10 Feb 2025
At a glance
- Drugs Sacubitril/valsartan (Primary)
- Indications Heart failure
- Focus Therapeutic Use
Most Recent Events
- 07 Feb 2025 Status changed from recruiting to completed.
- 05 Aug 2024 Planned End Date changed from 30 Jun 2024 to 31 Mar 2025.
- 05 Aug 2024 Planned primary completion date changed from 30 Jun 2024 to 31 Dec 2024.